Literature DB >> 16107334

Synthesis of anticoagulantly active heparan sulfate proteoglycans by glomerular epithelial cells involves multiple 3-O-sulfotransferase isoforms and a limiting precursor pool.

Eric P Girardin1, Sassan Hajmohammadi, Béatrice Birmele, Armin Helisch, Nicholas W Shworak, Ariane I de Agostini.   

Abstract

Endothelial and other select cell types synthesize a subpopulation of heparan sulfate (HS) proteoglycans (HSPGs), anticoagulant HSPGs (aHSPGs) that bear aHS-HS chains with the cognate 3-O-sulfated pentasaccharide motif that can bind and activate anti-thrombin (AT). Endothelial cells regulate aHSPG production by limiting levels of HS 3-O-sulfotransferase-1 (3-OST-1), which modifies a non-limiting pool of aHS-precursors. By probing kidney cryosections with (125)I-AT and fluorescently tagged AT we found that the glomerular basement membrane contains aHSPGs, with the staining pattern implicating synthesis by glomerular epithelial cells (GECs). Indeed, cultured GECs synthesized aHS with high AT affinity that was comparable with the endothelial product. Disaccharide analyses of human GEC (hGEC) HS in conjunction with transcript analyses revealed that hGECs express predominantly 3-OST-1 and 3-OST-3(A). aHS production has not been previously examined in cells expressing multiple 3-OST isoforms. This unusual situation appears to involve novel mechanisms to regulate aHS production, as HS structural analyses suggest hGECs exhibit excess levels of 3-OST-1 and an extremely limiting pool of aHS-precursor. A limiting aHS-precursor pool may serve to minimize aHS synthesis by non-3-OST-1 isoforms. Indeed, we show that high in vitro levels of 3-OST-3(A) can efficiently generate aHS. Non-3-OST-1 isoforms can generate aHS in vivo, as the probing of kidney sections from 3-OST-1-deficient mice revealed GEC synthesis of aHSPGs. Surprisingly, Hs3st1(-/-) kidney only expresses 3-OST isoforms having a low specificity for aHS synthesis. Thus, our analyses reveal a cell type that expresses multiple 3-OST isoforms and produces minimal amounts of aHS-precursor. In part, this mechanism should prevent aHS overproduction by non-3-OST-1 isoforms. Such a role may be essential, as 3-OST isoforms that have a low specificity for aHS synthesis can generate substantial levels of aHSPGs in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107334     DOI: 10.1074/jbc.M507997200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Proteoglycan synthesis and Golgi organization in polarized epithelial cells.

Authors:  Gunnar Dick; Linn K Akslen-Hoel; Frøy Grøndahl; Ingrid Kjos; Kristian Prydz
Journal:  J Histochem Cytochem       Date:  2012-09-01       Impact factor: 2.479

2.  Heparin impairs angiogenesis through inhibition of microRNA-10b.

Authors:  Xiaokun Shen; Jianping Fang; Xiaofen Lv; Zhicao Pei; Ying Wang; Songshan Jiang; Kan Ding
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

3.  HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis.

Authors:  Nicole C Smits; Takashi Kobayashi; Pratyaksh K Srivastava; Sladjana Skopelja; Julianne A Ivy; Dustin J Elwood; Radu V Stan; Gregory J Tsongalis; Frank W Sellke; Peter L Gross; Michael D Cole; James T DeVries; Aaron V Kaplan; John F Robb; Scott M Williams; Nicholas W Shworak
Journal:  Matrix Biol       Date:  2017-01-23       Impact factor: 11.583

4.  Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer.

Authors:  Péter Tátrai; Krisztina Egedi; Aron Somorácz; Toin H van Kuppevelt; Gerdy Ten Dam; Malcolm Lyon; Jon A Deakin; András Kiss; Zsuzsa Schaff; Ilona Kovalszky
Journal:  J Histochem Cytochem       Date:  2010-02-01       Impact factor: 2.479

5.  Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity.

Authors:  Ariane I de Agostini; Ji-Cui Dong; Corinne de Vantéry Arrighi; Marie-Andrée Ramus; Isabelle Dentand-Quadri; Sébastien Thalmann; Patricia Ventura; Victoria Ibecheole; Felicia Monge; Anne-Marie Fischer; Sassan HajMohammadi; Nicholas W Shworak; Lijuan Zhang; Zhenqing Zhang; Robert J Linhardt
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

6.  Hs3st3-modified heparan sulfate controls KIT+ progenitor expansion by regulating 3-O-sulfotransferases.

Authors:  Vaishali N Patel; Isabelle M A Lombaert; Samuel N Cowherd; Nicholas W Shworak; Yongmei Xu; Jian Liu; Matthew P Hoffman
Journal:  Dev Cell       Date:  2014-06-23       Impact factor: 12.270

7.  The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissues.

Authors:  Roger Lawrence; Tomio Yabe; Sassan Hajmohammadi; John Rhodes; Melissa McNeely; Jian Liu; Edward D Lamperti; Paul A Toselli; Miroslaw Lech; Patricia G Spear; Robert D Rosenberg; Nicholas W Shworak
Journal:  Matrix Biol       Date:  2007-03-30       Impact factor: 11.583

Review 8.  Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

Authors:  Bryan E Thacker; Ding Xu; Roger Lawrence; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

9.  The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer.

Authors:  X Mao; C Gauche; M W H Coughtrie; C Bui; S Gulberti; F Merhi-Soussi; N Ramalanjaona; I Bertin-Jung; A Diot; D Dumas; N De Freitas Caires; A M Thompson; J-C Bourdon; M Ouzzine; S Fournel-Gigleux
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

10.  Bioengineered Chinese hamster ovary cells with Golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site.

Authors:  Payel Datta; Guoyun Li; Bo Yang; Xue Zhao; Jong Youn Baik; Trent R Gemmill; Susan T Sharfstein; Robert J Linhardt
Journal:  J Biol Chem       Date:  2013-11-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.